reply to @cpt_yossarian
That's great speculation - but it would be a pretty significant non-disclosure if a decision had been taken to delay AMPLIFY until after Co-PSMA and not announce.
Hell of a left-field outcome either way. Success in Co-PSMA and Clarity gets treated like its reported positive interim Phase III results. Failure, and its possible the whole PSMA diagnostic regime gets binned.
Any idea what involvement (if any) the FDA has with the Co-PSMA trial? Or was only TGA approval required?
reply to @cpt_yossarianThat's great speculation - but it would...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.18 |
Change
-0.060(2.68%) |
Mkt cap ! $700.5M | |||
| Open | High | Low | Value | Volume |
| $2.24 | $2.28 | $2.17 | $3.806M | 1.722M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 52794 | $2.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.20 | 13567 | 3 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |